Current Appointments & Affiliations
Associate Professor of Neurology
·
2023 - Present
Neurology, MS & Neuroimmunology,
Neurology
Residency Program Director in the Department of Neurology
·
2023 - Present
Neurology,
Clinical Science Departments
Recent Publications
Impact of Caregiver Status on Academic Achievements and Family-Work Conflict: A Cross-Sectional Analysis of US Neurology Faculty.
Journal Article Neurol Clin Pract · October 2025 BACKGROUND AND OBJECTIVES: With more women entering the medical workforce, caregiving challenges and family-work conflicts are of growing importance to today's neurologists. The aim of this study was to assess the impact of caregiver (CG) status on academi ... Full text Link to item CiteRituximab in pathologically confirmed sarcoidosis affecting the central nervous system: a multi-center retrospective study.
Journal Article J Neurol · July 18, 2025 BACKGROUND: Rituximab, a monoclonal antibody that depletes B cells by targeting CD20, has been suggested as a treatment option for neurosarcoidosis, but evidence to support its use is limited. METHODS: Patients from four US medical centers with CNS sarcoid ... Full text Link to item CiteReal-World Treatment Outcomes in Black, Hispanic, Asian, and White Patients with Multiple Sclerosis Treated with Natalizumab.
Journal Article Drugs Real World Outcomes · June 2025 BACKGROUND: Multiple sclerosis (MS) is a heterogeneous disease that may manifest differently among racial/ethnic groups, influencing response to disease-modifying therapy (DMT). Data on natalizumab (NTZ) effectiveness in people with MS (PwMS) based on race ... Full text Link to item CiteRecent Grants
BEAT-MS
Clinical TrialPrincipal Investigator · Awarded by Benaroya Research Institute at Virginia Mason · 2020 - 2028A phase IV, prospective, multicenter, open-label, mothermilk study to evaluate ofatumumab concentration in the breast milk of lactating women with relapsing forms of multiple sclerosis receiving ofatumumab (Kesimpta ®
Clinical TrialPrincipal Investigator · Awarded by Novartis Pharmaceuticals Corporation · 2024 - 2027MOGAD -
Clinical TrialPrincipal Investigator · Awarded by Genentech, Inc. · 2024 - 2025View All Grants
Education, Training & Certifications
State University of New York Upstate Medical University ·
2013
M.D.